Medical tourism: way of the future or flight of fancy?

By David Woods ([email protected]) The European Union is moving to strengthen rights of EU patients to seek care in countries other than their own, while the UK government has stated that the National Health Service definitely won’t fund medical tourism. At the same time, India , Thailand , Korea and Thailand are all ramping up…

Is it time for a government-run national health system in the US?

By David Woods ([email protected]) With healthcare in the US consuming about 16% of GNP, or around 2 trillion dollars a year, and still leaving an estimated 47 million people uninsured, is it time for Americans to adopt a universal, government-run health system? Dr Walter Tsou (pictured right) certainly thinks so. A tireless advocate for such…

ISMPP: Former Merck CEO outlines three ways pharma companies can regain lost prestige

By David Woods ([email protected]) While the Golden Age of the pharmaceutical industry is over, and its reputation similar to that of the tobacco and oil industries, there is hope at hand – according to former Merck CEO Roy Vagelos. In a keynote address to the third annual meeting of the International Society for Medical Publication…

HOC people – Dennis M. Gross, PhD

By David Woods ([email protected]) On January 1st 2006, Dr Dennis Gross retired from Merck after 28 years; the following day, he took up his present position as Associate Dean, Masters Programs, in the College of Graduate Studies at Thomas Jefferson University. At Merck, he had started out as a senior research pharmacologist working on the…

HOC people – Vittorio Maio, PharmD, MPH

By David Woods ([email protected]) Entusiasmo. That’s a word that describes, in his native Italian, what Vittorio Maio brings to his work in health policy and outcomes research. “What makes me really happy,” he says, “is being able to see research theory translate into actual practice in the real world.” Vittorio graduated from the University of…

HOC people – Diana Brixner

By David Woods ([email protected]) Newly-installed ISPOR president Diana Brixner, RPh, PhD, has put together a challenging agenda for the society during her term of office. The central point of that agenda, she tells HOC, is to bridge the gap separating academics and outcomes researchers from the people who actually make economic decisions. Achieving that, she…

HOC people: Alan Bakst

By David Woods ([email protected]) “An opportunity and a challenge”. That’s what Alan Bakst found when he became Director of Health Economics and Outcomes Research at TAP pharmaceuticals in Chicago in August 2004. Up until then, TAP didn’t have a stable and fully staffed group in health outcomes, so the opportunity came in building the group.…